Your session is about to expire
← Back to Search
Hiprex for Recurring Urinary Tract Infections
Study Summary
This trial will test whether Hiprex, which contains formaldehyde, can help reduce the number of recurrent urinary tract infections in women.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 50 and 85 years old.I am female.I have a history of liver disease.I have a condition that affects how my bladder functions.I am currently taking antibiotics.My diabetes is not under control (HbA1c > 9).My kidney function is impaired with a creatinine level over 1.5 mg/dL.I have had at least 2 UTIs in the last 6 months or 3 in the last year.You are using a urinary catheter.You are allergic to Hiprex.
- Group 1: Group 1 - Patients with negative and positive urine culture
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Hiprex obtained authorization from the FDA?
"As Hiprex has already been approved, its safety rating is 3 on a scale of 1 to 3. This indicates that it has gone through numerous clinical trials and the results have demonstrated efficacy."
What is the total enrollment count for this clinical research?
"Affirmative. Clinicaltrials.gov hosts the evidence that this clinical trial is presently recruiting participants, with the first post date of April 1st 2021 and latest update on July 6th 2022. The study necessitates 20 patients from one medical centre for enrolment."
Is it possible to participate in this medical trial if one is over forty years of age?
"This clinical trial has age restrictions, requiring all participants to be at least 50 years old and no more than 85."
Are there any prior experiments involving Hiprex that have been conducted?
"Presently, only one study is in progress that uses Hiprex as a research subject and it has yet to reach its third phase. With the majority of trials for this medication occurring within Dallas, TX; there is still another location running examinations on Hiprex."
Are there still opportunities for enrollment in this experiment?
"Affirmative, details on clinicaltrials.gov reveal that this research is actively recruiting participants. It was initially posted on April 1st 2021 and most recently updated on July 6th 2022; 20 individuals must be recruited at one facility."
To what criteria must individuals comply in order to qualify for this clinical trial?
"This clinical trial seeks 20 females aged between 50-85 who have had a minimum of two urinary tract infections (UTIs) in the past 6 months, or three UTIs within the last year."
Share this study with friends
Copy Link
Messenger